Home > Insider Trading > Filing (0000899243-20-012349)

Filing Details

Accession Number:: 0000899243-20-012349
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-07 21:00:59
Reporting Period:: 2020-05-05

Accepted Time:: 2020-05-07 21:00:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673554	L David Kemmerly	3854 American Way, Suite A Baton Rouge LA 70816	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-05	18,750	$27.35	38,892	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	1,562	$27.35	40,454	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	3,125	$27.35	43,579	No	4	M	Direct
Common Stock	Disposition	2020-05-05	3,142	$174.41	40,437	No	4	S	Direct
Common Stock	Disposition	2020-05-05	13,858	$175.17	26,579	No	4	S	Direct
Common Stock	Disposition	2020-05-05	6,044	$176.04	20,535	No	4	S	Direct
Common Stock	Disposition	2020-05-05	393	$176.80	20,142	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-05-05	18,750	$0.00	18,750	$27.35
Common Stock	Stock Option (right to buy)	Disposition	2020-05-05	1,562	$0.00	1,562	$27.35
Common Stock	Stock Option (right to buy)	Disposition	2020-05-05	3,125	$0.00	3,125	$27.35

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2025-05-01	No	4	M	Direct
1,563	2025-05-01	No	4	M	Direct
3,125	2025-05-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	506	Indirect	Through 401(k) Plan

Footnotes

The total amount of shares beneficially owned includes 251 shares held in an employee stock purchase plan account.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.63 to $174.62, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.63 to $175.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.63 to $176.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
The information in this report is based on a plan statement dated as of March 31, 2020.
On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock, subject to time-based vesting conditions. 18,750 of the options vested on May 1, 2019, and the remaining 18,750 options vested on May 1, 2020. After the transaction being reported herein, the reporting person has exercised all of these time-based options.
On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 9,375 shares (the "2017 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2017 Tranche Options vested on each of May 1, 2018, May 1, 2019 and May 1, 2020. After the transaction being reported herein, 1,563 of the 2017 Tranche Options remain unexercised.
On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vested based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 9,375 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019, and the remaining two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transaction being reported herein, 3,125 of the 2018 Tranche Options remain unexercised.